Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0369820160460040325
Jorunal of Korean Pharmaceutical Sciences
2016 Volume.46 No. 4 p.325 ~ p.339
Nanoparticle-based combination drug delivery systems for synergistic cancer treatment
Choi Ju-Yeon

Thapa Raj Kumar
Yong Chul-Soon
Kim Jong-Oh
Abstract
Despite being a leading cause of death worldwide, cancer remains difficult to treat due to the development of drug resistance and severe adverse effects associated with conventional chemotherapy. Hence, combination chemotherapy is theoretically advantageous owing to the synergistic effects of drugs and suppression of drug resistance. Nanoparticle-mediated chemotherapeutic delivery is a promising approach for the effective treatment of various cancers because it may simultaneously enhance therapeutic effects and reduce side effects. The loading of multiple chemotherapeutic agents to these systems could additionally improve the antineoplastic efficacy. This review highlights recent advances in combination chemotherapy using small-molecule chemotherapeutic agents via nanocarrier systems, e.g., liposomes, polymeric micelles, dendrimers, polymer-drug conjugates, and mesoporous silica nanoparticles. Specifically, it emphasizes the unique properties of these systems that make them amenable to optimized treatments with respect to efficacy and safety and clarifies areas in which current therapeutic strategies can be improved.
KEYWORD
Nanoparticle, Combination chemotherapy, Synergistic effect, Nanocarrier
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)